Why Non-Compliant Cosmetic Labels Are Rising in Post-Brexit UK

Mon, 29 Jun 2026 17:36:23 GMT

Walk into a beauty retailer, a pharmacy chain or even a well-presented independent store in the UK today, and something becomes increasingly noticeable. Alongside strong, well positioned products, there are also items that do not fully meet Great Britain labelling requirements.

Missing Responsible Person details. No country of origin. Ingredient lists that are incomplete or not aligned with INCI nomenclature. Claims that do not clearly match the product’s intended function.

These are not isolated exceptions. They are appearing with increasing frequency across categories and price points.

The immediate assumption is often that these are simple compliance oversights. In reality, they reflect something deeper.

They are the visible result of a regulatory environment that has evolved faster than many product development and supply chains have adapted.

Not Random Errors, But Systemic Friction

It is easy to dismiss incorrect labelling as carelessness. However, when the same types of issues appear repeatedly across multiple brands and retail settings, the pattern suggests something more structural.

Many of these products are not inherently unsafe. They are, however, misaligned with the specific regulatory framework of the UK market.

This misalignment often originates earlier in the process. Products are developed for one regulatory landscape, typically the EU or global markets, and then extended into Great Britain without full adaptation.

The result is a product that works technically and commercially but fails in regulatory precision.

Brexit and the Creation of a Dual Compliance Reality

Since the UK left the European Union, cosmetic regulation has entered a more complex phase. While the UK retained much of the EU Cosmetic Regulation framework, it now operates as a distinct system with its own requirements.

For example:

Products sold in Great Britain must have a UK based Responsible Person with a full address on the label.
Products must be notified through the UK Submit Cosmetic Product Notification system rather than the EU portal.
Labelling must reflect UK specific requirements, even when the product is identical to an EU equivalent.

For brands operating across both markets, this creates a dual compliance burden. Separate Responsible Persons, separate notifications, and in some cases, distinct labelling strategies are required.

In practice, this is where many of the issues seen on shelf originate.

A product labelled correctly for the EU is not automatically compliant in Great Britain. Subtle differences, often considered minor during development, become critical at the point of sale.

What Is Actually Missing on Shelf

The gaps observed in retail align closely with the core requirements defined under UK cosmetic regulation.

Each product must clearly display:

Name and address of the Responsible Person
Country of origin for imported products
Ingredient list using INCI terminology
Batch number for traceability
Nominal content
Warnings and instructions for safe use

When these elements are absent, incomplete or incorrect, the issue is not just technical. It compromises traceability, accountability and consumer transparency.

These are foundational principles of cosmetic regulation, not optional details.

Who Carries the Risk

One of the most important and often misunderstood aspects is where responsibility sits.

The Responsible Person is legally accountable for ensuring that the product complies with all regulatory requirements before it is placed on the market.

For imported products, this responsibility frequently falls on the importer or a UK based representative.

If non-compliant products are identified, actions can include:

Market withdrawal
Product recalls
Enforcement notices
Financial penalties
In severe cases, legal consequences for the Responsible Person

Retailers are not entirely insulated. While they are not the primary accountable entity, they are expected to exercise due diligence. Selling non-compliant products can lead to product removal, disruption and reputational impact.

This is particularly relevant as enforcement visibility increases.

The Next Layer of Complexity: Digital Labelling

At the same time that businesses are adapting to post Brexit requirements, another shift is emerging.

Digital labelling.

Across both the EU and UK landscapes, there is growing interest in expanding the use of QR codes and digital platforms to provide additional product information.

At first glance, this appears to simplify communication. In reality, it introduces a new layer of complexity.

Digital tools can complement physical labels, but they do not replace mandatory on pack information. Core regulatory elements must still remain clearly visible and accessible on the product itself.

This creates a hybrid model where brands must manage:

Physical compliance requirements
Digital information accuracy
Consistency between platforms
Consumer accessibility

For companies already struggling with basic labelling adaptation, this adds another dimension to manage.

Why This Matters for Formulation and Development

It is tempting to view labelling as a final step, something to be addressed once the product is ready to launch.

This mindset is one of the root causes behind the issues seen in the market.

Labelling is not independent from formulation. It is a direct reflection of decisions made during development.

Ingredient selection determines what must be declared
Fragrance composition influences allergen labelling
Claims define the level of evidence required
Packaging format affects how information is presented

When these elements are not aligned early, compliance becomes reactive rather than designed.

This is why non-compliant products are not simply regulatory failures. They are development failures that only become visible at the final stage.

A Market Moving Toward Greater Scrutiny

The UK regulatory environment is not static. Enforcement is becoming more visible, and expectations are increasing.

At the same time, consumers are more informed. They read labels, compare products and question claims.

This creates a dual pressure. Products must satisfy regulatory requirements while also maintaining credibility in the eyes of the consumer.

In this context, incomplete or incorrect labelling is not just a compliance issue. It is a trust issue.

From Reaction to Designed Compliance

The recurrence of labelling non-compliance should not be interpreted as isolated execution errors. It reflects a systemic misalignment between regulatory requirements and product development workflows.

In many development models, regulatory review is positioned downstream, after formulation selection, claims definition and packaging design. At that stage, the available degrees of freedom are already constrained. Adjustments to achieve compliance often require reformulation, relabelling or modification of claims, all of which introduce additional complexity, cost and risk.

From a technical standpoint, labelling is not an independent variable. It is a direct output of formulation composition, ingredient functionality, safety assessment and intended use conditions. Each of these parameters is defined during early development stages.

For example:

Ingredient selection determines declaration requirements and potential restrictions
Fragrance composition defines allergen disclosure obligations
Product format and application define warning statements and instructions for use
Claimed function determines the type and level of substantiation required

If these inputs are not specified with regulatory endpoints in mind, the resulting product will require downstream correction.

A more robust approach is to treat compliance as a design constraint rather than a verification step. This involves integrating regulatory criteria into formulation design, claims architecture and packaging development from the outset.

Under this model, compliance is not assessed after completion. It is engineered as an inherent property of the system.

This shift reduces late-stage variability, improves development efficiency and results in products that are consistently aligned with both regulatory frameworks and market expectations.

Compliance as a Measure of Product Quality

The products that succeed going forward will not simply be those that perform well. They will be those that are designed to withstand scrutiny.

Clear labelling, credible claims and regulatory alignment are becoming part of how product quality is judged. Labelling is a marker of a well-designed, well thought through product.

If you are placing products on the UK market and want to ensure that your formulations, claims and labelling are fully aligned with current and emerging regulatory expectations, this is the moment to review your approach.

At Olalla Consulting, I work across formulation, regulatory strategy and product development to support brands, importers and retailers in building products that are technically strong, commercially viable and fully compliant.

👉 Explore more at https://blog.olallaconsulting.com and start designing products that stand up to real world scrutiny.

Absolutely, this will now position you as a regulatory authority with real market visibility, not just theory. I’ve aligned everything to your refined blog angle, ensured SEO strength, and kept tone consistent with premium technical branding.

The Green Chem Hive